Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Diverse Organizations Join CCHR in Call for Ban on Electroshocking Children Including the Nation of Islam, NAACP and Black Lives Matter
  • USA - English


News provided by

Citizens Commission on Human Rights

May 17, 2016, 09:00 ET

Share this article

Share toX

Share this article

Share toX


Atlanta, Georgia (PRWEB) May 17, 2016 -- One would expect the Citizens Commission on Human Rights (CCHR), the international mental health watchdog established by the Church of Scientology and Professor of Psychiatry Thomas Szasz, to take a stand against electroshocking of children. But when CCHR takes that message to the heart of Atlanta during the annual convention of the American Psychiatric Association (APA)—and is joined by representatives of the NAACP, the Nation of Islam, 10,000 Fearless Men, Black Lives Matter and Concerned Black Clergy—one has to look deeper.

There are no indications for the use of ECT on minors, and hence this should be prohibited through legislation. — Donzella James, Georgia State Senator

Post this

“Electroconvulsive Therapy,” otherwise known as “ECT” or electroshock treatment, is a technique invented in the 1930s, which sends electricity into the brain, inducing a seizure. It’s associated with numerous side-effects, including short and long-term memory loss, cognitive problems, manic symptoms, prolonged seizures, heart problems and death.[1]

Participants in the protest reported that bystanders were “shocked” to learn this practice is still common, stunned to learn that the APA is currently pressuring the Food and Drug Administration to reclassify the ECT devised to include its use against children.[2] “You mean they still do that?” responded one of the march viewers, a security guard on the property where the APA event took place. “I thought that went out in the ‘40s!”

Not so, says Mental Health America, reporting that “ECT is administered to an estimated 100,000 people a year, primarily in general hospital psychiatric units and in psychiatric hospitals.”[3] And this while FDA agencies are already aware it is a dangerous procedure. In fact, the FDA’s Office of Device Evaluation, a part of the Center for Devices and Radiological Health, issued a draft guidance in early 2016 recommending a “prominently placed” warning on ECT devices to include “The long-term safety and effectiveness of ECT treatment has not been demonstrated.”[4]

The same report lists effects known to be associated with ECT, ranging from:

  • Long-term problems with “autobiographical memory” (knowledge about one’s own life)
  • Pain and skin burns
  • Insufficient, or lack of breathing
  • Heart attack
  • Stroke
  • Death [4]

So as the march led to a panel discussion on ECT, and the panel discussion into a symposium the following day, attendees asked, “Why on Earth would anyone in their right mind push to use this against children?” Especially when one speaker, an ECT survivor who received “30 rounds of electroshock” in one year, at age 21, described how he had not one memory from his high school years, and broke into tears while recounting “sitting there, and my father having to teach me how to tie my shoes again.”

One participant seemed to have the answer. “This is unconscionable to even consider doing this to a child,” said Dr. Linda Lagemann, a clinical psychologist who retired after 23 years in practice. “Someone’s getting rich and someone’s getting hurt. This really must be stopped.”

Long-term Georgia State Senator Donzella James, speaking during the panel, called for state legislation to ban the use of ECT on children. She said Georgia’s provisions to protect children and others from ECT were grossly insufficient and cited a World Health Organization recommendation to governments that: “There are no indications for the use of ECT on minors, and hence this should be prohibited through legislation.”[5]

Panel Member Reverend Fred Shaw stated that the unanimous, resounding and spontaneous support for James’ proposal, a proposal so natural it should have long since been law, suddenly explained what brought together this particular mix of political persuasions, religious affiliations and socioeconomic delineations, and gave hope that, at least when it comes to our children, we can find unity amongst diversity.

About Citizens Commission on Human Rights: CCHR is a non-profit, non-political, non-religious mental health watchdog. Its mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. CCHR has helped to enact more than 150 laws protecting individuals from abusive or coercive mental health practices.

Click here for more information.

References:

[1] “Electroconvulsive Therapy (ECT) Devices for Class II Intended Uses,” Draft Guidance for Industry, Clinicians and Food and Drug Administration Staff, December 29, 2015, pp. 13-14, fda.gov/downloads/MedicalDevices/UCM478942.pdf.
[2] Letter to Robert M. Califf, M.D., Commissioner, U.S. Food and Drug Administration, from the American Psychiatric Association, March 10, 2016, p. 2, psychiatry.org/psychiatrists/advocacy/federal-affairs/patient-safety, click on: "March 10: APA Comments to the FDA Concerning the Proposed Order and Draft Guidance related to ECT Devices."
[3] “Electroconvulsive Therapy (ECT),” Mental Health America, mentalhealthamerica.net/ect.
[4] Op. cit., “Electroconvulsive Therapy (ECT) Devices for Class II Intended Uses,” Draft Guidance for Industry, Clinicians and Food and Drug Administration Staff.
[5] Benedetto Saraceno, MD, “WHO RESOURCE BOOK ON MENTAL HEALTH, HUMAN RIGHTS AND LEGISLATION WHO 2005,” p. 64, who.int/mental_health/policy/legislation/Resource%20Book_Eng2_WEB_07%20(2).pdf.

Media Department, Citizens Commission on Human Rights, http://www.cchrint.org, +1 (323) 467-4242, [email protected]

Modal title

A panel discussion on ECT with Gerald Griggs (Vice Pres. NAACP Atlanta), Rizza (Nation of Islam), Rev. Fred Shaw (Christian Minster), Sen. Donzella James, Dr. Linda Lagemann and Congressman Dan Burton
A panel discussion on ECT with Gerald Griggs (Vice Pres. NAACP Atlanta), Rizza (Nation of Islam), Rev. Fred Shaw (Christian Minster), Sen. Donzella James, Dr. Linda Lagemann and Congressman Dan Burton
ECT survivor Ken gave emotional testimony about how he received “30 rounds of electroshock” in one year when he was 21. He described how he didn't have even one memory from his high school years
ECT survivor Ken gave emotional testimony about how he received “30 rounds of electroshock” in one year when he was 21. He described how he didn't have even one memory from his high school years
A panel discussion on ECT with Gerald Griggs (Vice Pres. NAACP Atlanta), Rizza (Nation of Islam), Rev. Fred Shaw (Christian Minster), Sen. Donzella James, Dr. Linda Lagemann and Congressman Dan Burton ECT survivor Ken gave emotional testimony about how he received “30 rounds of electroshock” in one year when he was 21. He described how he didn't have even one memory from his high school years

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.